Skip to main content
GOVX
NASDAQ Life Sciences

GeoVax Labs Implements 1-for-25 Reverse Stock Split

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.64
Mkt Cap
$179.277M
52W Low
$0.115
52W High
$4.4
52W Position
Off High info
17% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

GOVX filed a Corporate Governance and Compliance on light trading volume (0.2× avg).

Summary

GeoVax Labs, Inc. has implemented a 1-for-25 reverse stock split, effective January 9, 2026, to increase its per-share price.


Key Events · Corporate Governance and Compliance · GOVX

  • Reverse Stock Split Implemented

    GeoVax Labs, Inc. filed a Certificate of Amendment to its Certificate of Incorporation to effect a 1-for-25 reverse stock split.

  • Effective Date

    The reverse stock split became effective on January 9, 2026.

  • Fractional Shares Handled

    No fractional shares will be issued; instead, they will be rounded up to the nearest whole share.

  • Ownership Unchanged

    Each stockholder's percentage ownership interest and proportional voting power remain substantially unchanged, aside from minor adjustments due to rounding.


Analysis · GOVX · Life Sciences

The 1-for-25 reverse stock split is a significant corporate action typically undertaken by companies to raise their per-share price, often to meet exchange listing requirements. While this action does not change the company's overall market capitalization or a shareholder's proportional ownership, it frequently signals underlying challenges or a need to improve stock perception. The rounding up of fractional shares is a minor benefit for affected shareholders. Investors should monitor the company's stock performance and future operational updates to understand the long-term implications of this action.

At the time of this filing, GOVX was trading at $3.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $179.3M. The 52-week trading range was $0.12 to $4.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GOVX - Latest Insights

GOVX
Jul 27, 2026, 4:34 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7599
Real-time Price: $0.7001 info
Change: -$0.0598 (-8%) info
Market Cap: $5.355M info
GOVX
Jul 27, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7599
Real-time Price: $0.7001 info
Change: -$0.0598 (-8%) info
Market Cap: $5.355M info
GOVX
Jul 10, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.19
Real-time Price: $0.7001 info
Change: -$0.4899 (-41%) info
Market Cap: $5.355M info
GOVX
Jun 17, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.15
Real-time Price: $0.7001 info
Change: -$0.4499 (-39%) info
Market Cap: $5.355M info
GOVX
May 26, 2026, 9:00 AM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $3.65
Real-time Price: $0.7001 info
Change: -$2.95 (-81%) info
Market Cap: $5.355M info